Stock A221800 U2BIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News U2Bio Co., Ltd.

Equities

A221800

KR7221800006

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-17 pm EDT 		5-day change 1st Jan Change
3,900 KRW -1.27% Intraday chart for U2Bio Co., Ltd. -8.13% -26.14%
2023 U2Bio Co., Ltd. has filed an IPO. CI
2020 Chang Moo Jeon acquired 8.5% stake in U2Bio CO. LTD. from MAC Fund, L.P. (Class B), a fund managed by M-Venture Investment, Inc. for KRW 1.6 billion. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
U2Bio Co., Ltd. has filed an IPO.
CI
Chang Moo Jeon acquired 8.5% stake in U2Bio CO. LTD. from MAC Fund, L.P. (Class B), a fund managed by M-Venture Investment, Inc. for KRW 1.6 billion.
CI
U2Bio CO. LTD. announced that it has received KRW 7 billion in funding
CI
U2Bio CO. LTD. announced that it expects to receive KRW 7 billion in funding
CI
NDS Corporation acquired additional 11.9% stake in U2Bio CO. LTD. from BSK Potential Fund 1, fund of BSK Investment for KRW 3.8 billion.
CI
NDS Corporation acquired 11.85% stake in U2Bio CO. LTD. for KRW 3.8 billion.
CI
An undisclosed buyer acquired 5.26% stake in U2Bio CO. LTD. from CKD Venture Fund 4 managed by CKD Venture Capital Co., Ltd. for KRW 1.1 billion.
CI
U2Bio CO. LTD. announced that it has received KRW 1.5 billion in funding
CI
U2Bio CO. LTD. announced that it expects to receive KRW 1.5 billion in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A221800 Stock
  4. News U2Bio Co., Ltd.